Animals expressing Mamu-A*01, -B*17, and -B*29 have reduced viral loads and increased survivorship. Plasma viral loads and survivorship were followed in 51 SIVmac239-infected rhesus macaques. Viral load trend lines were calculated as described in the legend for Fig. 1. Survivorship curves include only animals that have been sacrificed. Animals that remain alive are shown as open circles. The number of weeks postinfection is shown inside each animal's open circle. There are seven Mamu-A*01-positive animals alive at 57 weeks postinfection, of which only three are Mamu-A*01, -B*17, and -B*29 positive. (A) In 16 Mamu-A*01-, -B*17-, and -B*29-negative macaques, median survivorship was 44 weeks, with a setpoint viral load in excess of 1,000,000 copies per ml of blood plasma. (B) Mamu-A*01-positive, Mamu-B*17-, and -B*29-negative animals have slightly improved outcomes relative to Mamu-A*01-, -B*17-, and -B*29-negative macaques in terms of plasma viral load and survivorship. (C) The two Mamu-B*17- and -B*29-positive, Mamu-A*01-negative animals have slightly improved survivorship relative to the Mamu-A*01-, -B*17-, and -B*29-negative macaques. (D) All six Mamu-A*01-, -B*17-, and -B*29-positive macaques remain alive with significantly lower viral loads than the Mamu-A*01-, -B*17-, and -B*29-negative controls.